As of the latest Form 4 filed Apr 1, 2026.
What Accuray Incorporated insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 14 most recent filings for ARAY.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | 2026-03-31 | Chalke Sandeep SVP, Chief Commercial Officer | FTax | −40.0K | $0.39 | $15.5K | No | Form 4 ↗ |
| 2026-03-03 | 2026-02-28 | Peralta Leonel SVP, Chief Operations Officer | FTax | −29.0K | $0.55 | $15.9K | No | Form 4 ↗ |
| 2026-03-03 | 2026-02-28 | Peralta Leonel, SVP, Chief Operations Officer | MExercise | +83.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-20 | MAYER STEVEN F Director | PPurchase | +54.9K | $0.56 | $30.9K | No | Form 4 ↗ |
| 2026-02-20 | 2026-02-19 | MAYER STEVEN F Director | PPurchase | +69.0K | $0.53 | $36.6K | No | Form 4 ↗ |
| 2026-02-20 | 2026-02-18 | MAYER STEVEN F, Director | PPurchase | +126K | $0.53 | $67.2K | No | Form 4 ↗ |
| 2026-01-09 | 2025-12-31 | Scott Byron C Director | FTax | −3.77K | $0.82 | $3.11K | No | Form 4 ↗ |
| 2026-01-09 | 2025-12-31 | Scott Byron C, Director | MExercise | +9.43K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-12-02 | 2025-12-01 | Pervaiz Ali SVP Chief Financial Officer | FTax | −57.3K | $1.02 | $58.5K | No | Form 4 ↗ |
| 2025-12-02 | 2025-12-01 | Chalke Sandeep SVP, Chief Commercial Officer | FTax | −64.5K | $1.02 | $65.8K | No | Form 4 ↗ |
| 2025-12-02 | 2025-11-29 | Pervaiz Ali SVP Chief Financial Officer | MExercise | +44.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-12-02 | 2025-11-29 | Chalke Sandeep SVP, Chief Commercial Officer | MExercise | +50.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-12-02 | 2025-11-28 | Galbato Chan Director | AAward | +50.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-12-02 | 2025-11-28 | MAYER STEVEN F Director | AAward | +895K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ARAY’s full analysis or the market-wide insider trading feed. The tabs above jump to ARAY’s other SEC data.
Source: SEC Form 4 filings for ARAY, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.